<article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         dtd-version="1.0"
         article-type="research-article">
   <front>
      <journal-meta>
         <journal-id journal-id-type="jstor">finamana</journal-id>
         <journal-id journal-id-type="jstor">j100419</journal-id>
         <journal-title-group>
            <journal-title>Financial Management</journal-title>
         </journal-title-group>
         <publisher>
            <publisher-name>Financial Management Association International</publisher-name>
         </publisher>
         <issn pub-type="ppub">00463892</issn>
         <issn pub-type="epub">1755053X</issn>
         <custom-meta-group/>
      </journal-meta>
      <article-meta>
         <article-id pub-id-type="jstor">30134007</article-id>
         <title-group>
            <article-title>Concentrated Announcements on Clustered Data: An Event Study on Biotechnology Stocks</article-title>
         </title-group>
         <contrib-group>
            <contrib>
               <string-name>
                  <given-names>Véronique</given-names>
                  <surname>Bastin</surname>
               </string-name>
            </contrib>
            <contrib>
               <string-name>
                  <given-names>Georges</given-names>
                  <surname>Hübner</surname>
               </string-name>
            </contrib>
         </contrib-group>
         <pub-date>
            <day>1</day>
            <month>4</month>
            <year>2006</year>
         </pub-date>
         <volume xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">35</volume>
         <issue xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">1</issue>
         <issue-id>i30133999</issue-id>
         <fpage>129</fpage>
         <lpage>157</lpage>
         <permissions>
            <copyright-statement>Copyright 2006 Financial Management Association International</copyright-statement>
         </permissions>
         <self-uri xlink:href="https://www.jstor.org/stable/30134007"/>
         <abstract>
            <p>In spring 2000, three events-two political statements by Bill Clinton and Tony Blair and a breakthrough announcement by Celera Genomics-had a major impact on biotechnology stocks. We analyze their effects over a comprehensive set of biopharmaceutical companies, using a composite return-generating model with an industry-specific patent-based factor. Our results show that stocks can be clustered according to their responsiveness to political and scientific events. Furthermore, we emphasize different impacts on the market value of intangible assets for each cluster, suggesting that growth options are valued with different criteria for therapeutics, and technology-based subsectors.</p>
         </abstract>
         <custom-meta-group>
            <custom-meta>
               <meta-name>lang</meta-name>
               <meta-value>eng</meta-value>
            </custom-meta>
         </custom-meta-group>
      </article-meta>
   </front>
   <back>
      <fn-group>
         <title>[Footnotes]</title>
         <fn id="d43e281a1310">
            <label>1</label>
            <p>
               <mixed-citation id="d43e288" publication-type="other">
http://www.signalsmag.com/.</mixed-citation>
            </p>
         </fn>
         <fn id="d43e295a1310">
            <label>2</label>
            <p>
               <mixed-citation id="d43e302" publication-type="other">
Scholes and Williams (1977)</mixed-citation>
            </p>
            <p>
               <mixed-citation id="d43e308" publication-type="other">
Dimson (1979)</mixed-citation>
            </p>
         </fn>
      </fn-group>
      <ref-list>
         <title>References</title>
         <ref id="d43e324a1310">
            <mixed-citation id="d43e328" publication-type="other">
Al-Horani, A., P.E. Pope, and A.W. Stark, 2003, "Research and Development Activity and Expected Returns
in the United Kingdom," European Finance Review 7, 27-46.</mixed-citation>
         </ref>
         <ref id="d43e338a1310">
            <mixed-citation id="d43e342" publication-type="other">
Angbazo, L.A. and R. Narayanan, 1996, "Catastrophic Shocks in the Property-Liability Insurance Industry:
Evidence on Regulatory and Contagion Effects," Journal of Risk and Insurance 63, 619-637.</mixed-citation>
         </ref>
         <ref id="d43e352a1310">
            <mixed-citation id="d43e356" publication-type="other">
Austin, D.A., 1993, "An Event Study Approach to Measuring Innovative Output: The Case of
Biotechnology," American Economic Review 83, 253-258.</mixed-citation>
         </ref>
         <ref id="d43e366a1310">
            <mixed-citation id="d43e370" publication-type="other">
Biotechnology Industry Organization, 2000, "BIO Responds To Clinton, Blair Statement On Gene-Based
Health-Care Research," Press Release, March 14.</mixed-citation>
         </ref>
         <ref id="d43e381a1310">
            <mixed-citation id="d43e385" publication-type="other">
Brooks, R., R.A. Faff, D. Hillier and J. Hillier, 2004, "The National Market Impact of Sovereign Rating
Changes," Journal of Banking and Finance 28, 233-250.</mixed-citation>
         </ref>
         <ref id="d43e395a1310">
            <mixed-citation id="d43e399" publication-type="other">
Campbell, C.J. and C.E. Wasley, 1993, "Measuring Security Price Performance using Daily NASDAQ
Returns," Journal of Financial Economics 33, 73-92.</mixed-citation>
         </ref>
         <ref id="d43e409a1310">
            <mixed-citation id="d43e413" publication-type="other">
Celera Genomics, 2000a, "Celera Compiles DNA Sequence Covering 90% of the Human Genome," Company
Press Release, January 10.</mixed-citation>
         </ref>
         <ref id="d43e423a1310">
            <mixed-citation id="d43e427" publication-type="other">
Celera Genomics, 2000b, "Celera Statement on the Policy Statement of President Clinton and Prime Minister
Blair on the Availability of Genomic Information," Company Press Release, March 14.</mixed-citation>
         </ref>
         <ref id="d43e437a1310">
            <mixed-citation id="d43e441" publication-type="other">
Celera Genomics, 2000c, "Celera Genomics Completes Sequencing Phase of the Genome from One Human
Being," Company Press Release, April 6.</mixed-citation>
         </ref>
         <ref id="d43e451a1310">
            <mixed-citation id="d43e455" publication-type="other">
Chan, L.K.C., J. Lakonishok, and T. Sougiannis, 2001, "The Stock Market Valuation of Research and
Development Expenditures," Journal of Finance 56, 2431-2456.</mixed-citation>
         </ref>
         <ref id="d43e466a1310">
            <mixed-citation id="d43e470" publication-type="other">
Chiou, I. and L.J. White, 2005, "Measuring the Value of Strategic Alliances in the Wake of a Financial
Implosion: Evidence from Japan's Financial Services Sector," Journal of Banking and Finance 29, 2455-
2473.</mixed-citation>
         </ref>
         <ref id="d43e483a1310">
            <mixed-citation id="d43e487" publication-type="other">
Cornett, M.M. and J. Musumeci, 1999, "How Legislation Affects Value: The Failure of Credit Card Cap
Legislation," Financial Management 28, 83-94.</mixed-citation>
         </ref>
         <ref id="d43e497a1310">
            <mixed-citation id="d43e501" publication-type="other">
Degami, S. and J. Van Brunt, 2000, "Financial Snapshot for March: Volatility Rules," March.
www.signalsmag.com.</mixed-citation>
         </ref>
         <ref id="d43e511a1310">
            <mixed-citation id="d43e515" publication-type="other">
Dimson, E., 1979, "Risk Measurement when Shares are Subject to Infrequent Trading," Journal of Financial
Economics 7, 197-226.</mixed-citation>
         </ref>
         <ref id="d43e525a1310">
            <mixed-citation id="d43e529" publication-type="other">
Dohlman, E., T. Hall, andA. Somwaru, 2002, "Regulatory Events and Biotech Firm Share Prices," Review of
Agricultural Economics 24, 108-122.</mixed-citation>
         </ref>
         <ref id="d43e539a1310">
            <mixed-citation id="d43e543" publication-type="other">
Eades, K.M., P.J. Hess, and E.H. Kim, 1994, "Time-Series Variation in Dividend Pricing," Journal of
Finance 49, 1617-1638.</mixed-citation>
         </ref>
         <ref id="d43e554a1310">
            <mixed-citation id="d43e558" publication-type="other">
Eisenberg, R., 2003, "Patenting Genome Research Tools and the Law," Comptes Rendus Biologies 326,
1115-1120.</mixed-citation>
         </ref>
         <ref id="d43e568a1310">
            <mixed-citation id="d43e572" publication-type="other">
Fama, E.F. and K.R. French, 1992, "The Cross-Section of Expected Stock Returns," Journal of Finance 47,
427-465.</mixed-citation>
         </ref>
         <ref id="d43e582a1310">
            <mixed-citation id="d43e586" publication-type="other">
Fama, E.F. and K.R. French, 1993, "Common Risk Factors in the Returns on Stocks and Bonds," Journal of
Financial Economics 33, 3-56.</mixed-citation>
         </ref>
         <ref id="d43e596a1310">
            <mixed-citation id="d43e600" publication-type="other">
Karafiath, I., 1988, "Using Dummy Variables in the Event Methodology," Financial Review 23, 351-357.</mixed-citation>
         </ref>
         <ref id="d43e607a1310">
            <mixed-citation id="d43e611" publication-type="other">
Kellogg, D. and J.M. Charnes, 2000, "Real-Options Valuation for a Biotechnology Company," Financial
Analyst Journal 56, 76-84.</mixed-citation>
         </ref>
         <ref id="d43e621a1310">
            <mixed-citation id="d43e625" publication-type="other">
Lerner, J., 1994, "The Importance of Patent Scope: An Empirical Analysis," RAND Journal of Economics
25, 319-333.</mixed-citation>
         </ref>
         <ref id="d43e636a1310">
            <mixed-citation id="d43e640" publication-type="other">
Ottoo, R.E., 1998, "Valuation of Internal Growth Opportunities: The Case of a Biotechnology Company,"
Quarterly Review of Economics and Finance 38, 615-633.</mixed-citation>
         </ref>
         <ref id="d43e650a1310">
            <mixed-citation id="d43e654" publication-type="other">
Ryan, H.E. and R.A. Wiggins, 2002, "The Interactions Between R&amp;D Investment Decisions and Compensation
Policy," Financial Management 31, 5-29.</mixed-citation>
         </ref>
         <ref id="d43e664a1310">
            <mixed-citation id="d43e668" publication-type="other">
Scholes, M. and J.T. Williams, 1977, "Estimating Betas from Nonsynchronous Data," Journal of Financial
Economics 5, 309-327.</mixed-citation>
         </ref>
         <ref id="d43e678a1310">
            <mixed-citation id="d43e682" publication-type="other">
Shreeve, J., 2004, The Genome War: How Craig Venter Tried to Capture the Code of Life and Save the World,
New York, NY, Knopf.</mixed-citation>
         </ref>
         <ref id="d43e692a1310">
            <mixed-citation id="d43e696" publication-type="other">
White House, 2000a, "joint Statement by President Clinton and Prime Minister Tony Blair of the UK,"
March 14. http://clinton6.nara.gov/2000/03/2000-03-14-joint-statement-with-the-uk-on-the-human-
genome-project.html.</mixed-citation>
         </ref>
         <ref id="d43e709a1310">
            <mixed-citation id="d43e713" publication-type="other">
White House, 2000b, "Remarks by the President and the Participants in First Session of Economic Summit,"
April 5. http://clinton6.nara.gov/2000/04/2000-04-05-remarks-in-first-session-of-economic-summit.html.</mixed-citation>
         </ref>
         <ref id="d43e724a1310">
            <mixed-citation id="d43e728" publication-type="other">
Zellner, A., 1962, "An Efficient Method of Estimating Seemingly Unrelated Regressions and Tests for
Aggregation Bias," Journal of the American Statistical Association 57, 348-368.</mixed-citation>
         </ref>
         <ref id="d43e738a1310">
            <mixed-citation id="d43e742" publication-type="other">
Ziebart, D.A. and D.H. Kim, 1987, "An Examination of the Market Reactions Associated with SFAS No. 8
and SFAS No. 52," Accounting Review 62, 343-357.</mixed-citation>
         </ref>
      </ref-list>
   </back>
</article>
